Ardelyx, Inc.
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which h…
Biotechnology
US, Waltham [HQ]
News
Theses · Events · SentimentsArticles
24-12-24
Ardelyx, Inc. (NASDAQ:ARDX) Capital Efficiency Analysis
Ardelyx, Inc. (NASDAQ:ARDX) has a Return on Invested Capital (ROIC) of -24.68%, indicating …